Indicator type	Execution Sectors	Total
Units carrying out R&D in Biotechnology	Total	1,575
Units carrying out R&D in Biotechnology	Public Administration	116
Units carrying out R&D in Biotechnology	Higher Education	68
Units carrying out R&D in Biotechnology	Companies	1,376
Units carrying out R&D in Biotechnology	NPPI	15
% Units by type of biotechnology used: Genetic Code	Total	38.4
% Units by type of biotechnology used: Genetic Code	Public Administration	90.5
% Units by type of biotechnology used: Genetic Code	Higher Education	91.2
% Units by type of biotechnology used: Genetic Code	Companies	31.4
% Units by type of biotechnology used: Genetic Code	NPPI	33.3
% Units by type of biotechnology used: Functional Units	Total	48.9
% Units by type of biotechnology used: Functional Units	Public Administration	86.2
% Units by type of biotechnology used: Functional Units	Higher Education	91.2
% Units by type of biotechnology used: Functional Units	Companies	43.7
% Units by type of biotechnology used: Functional Units	NPPI	40.0
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Total	28.8
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Public Administration	67.2
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Higher Education	80.9
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Companies	22.8
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	NPPI	46.7
% Units by type of biotechnology used: Bioprocesses	Total	50.9
% Units by type of biotechnology used: Bioprocesses	Public Administration	59.5
% Units by type of biotechnology used: Bioprocesses	Higher Education	92.7
% Units by type of biotechnology used: Bioprocesses	Companies	48.3
% Units by type of biotechnology used: Bioprocesses	NPPI	33.3
% Units by type of biotechnology used: Subcellular Organisms	Total	13.8
% Units by type of biotechnology used: Subcellular Organisms	Public Administration	50.9
% Units by type of biotechnology used: Subcellular Organisms	Higher Education	67.7
% Units by type of biotechnology used: Subcellular Organisms	Companies	7.9
% Units by type of biotechnology used: Subcellular Organisms	NPPI	26.7
% Units by type of biotechnology used: Bioinformatics	Total	33.1
% Units by type of biotechnology used: Bioinformatics	Public Administration	73.3
% Units by type of biotechnology used: Bioinformatics	Higher Education	85.3
% Units by type of biotechnology used: Bioinformatics	Companies	27.1
% Units by type of biotechnology used: Bioinformatics	NPPI	33.3
% Units by type of biotechnology used: Nanobiotechnology	Total	16.9
% Units by type of biotechnology used: Nanobiotechnology	Public Administration	50.0
% Units by type of biotechnology used: Nanobiotechnology	Higher Education	75.0
% Units by type of biotechnology used: Nanobiotechnology	Companies	11.2
% Units by type of biotechnology used: Nanobiotechnology	NPPI	13.3
% Units by type of biotechnology used: Other	Total	16.5
% Units by type of biotechnology used: Other	Public Administration	7.8
% Units by type of biotechnology used: Other	Higher Education	8.8
% Units by type of biotechnology used: Other	Companies	17.6
% Units by type of biotechnology used: Other	NPPI	20.0
Units in which biotechnology activities are: Main and/or exclusive	Total	752
Units in which biotechnology activities are: Main and/or exclusive	Public Administration	27
Units in which biotechnology activities are: Main and/or exclusive	Higher Education	6
Units in which biotechnology activities are: Main and/or exclusive	Companies	711
Units in which biotechnology activities are: Main and/or exclusive	NPPI	8
Units in which biotechnology activities are: A secondary business line	Total	354
Units in which biotechnology activities are: A secondary business line	Public Administration	39
Units in which biotechnology activities are: A secondary business line	Higher Education	42
Units in which biotechnology activities are: A secondary business line	Companies	270
Units in which biotechnology activities are: A secondary business line	NPPI	3
Units in which biotechnology activities are: A necessary tool for production	Total	469
Units in which biotechnology activities are: A necessary tool for production	Public Administration	50
Units in which biotechnology activities are: A necessary tool for production	Higher Education	20
Units in which biotechnology activities are: A necessary tool for production	Companies	395
Units in which biotechnology activities are: A necessary tool for production	NPPI	4
% Units by final application areas of biotechnology use: Human Health	Total	52.3
% Units by final application areas of biotechnology use: Human Health	Public Administration	78.5
% Units by final application areas of biotechnology use: Human Health	Higher Education	92.7
% Units by final application areas of biotechnology use: Human Health	Companies	48.0
% Units by final application areas of biotechnology use: Human Health	NPPI	60.0
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Total	18.7
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Public Administration	18.1
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Higher Education	60.3
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Companies	16.9
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	NPPI	6.7
% Units by final application areas of biotechnology use: Food Products	Total	31.1
% Units by final application areas of biotechnology use: Food Products	Public Administration	25.0
% Units by final application areas of biotechnology use: Food Products	Higher Education	80.9
% Units by final application areas of biotechnology use: Food Products	Companies	29.4
% Units by final application areas of biotechnology use: Food Products	NPPI	6.7
% Units by final application areas of biotechnology use: Agriculture and Forestry	Total	27.3
% Units by final application areas of biotechnology use: Agriculture and Forestry	Public Administration	22.4
% Units by final application areas of biotechnology use: Agriculture and Forestry	Higher Education	72.1
% Units by final application areas of biotechnology use: Agriculture and Forestry	Companies	25.7
% Units by final application areas of biotechnology use: Agriculture and Forestry	NPPI	13.3
% Units by final application areas of biotechnology use: Environment	Total	20.9
% Units by final application areas of biotechnology use: Environment	Public Administration	23.3
% Units by final application areas of biotechnology use: Environment	Higher Education	73.5
% Units by final application areas of biotechnology use: Environment	Companies	18.0
% Units by final application areas of biotechnology use: Environment	NPPI	26.7
% Units by final application areas of biotechnology use: Industry	Total	15.5
% Units by final application areas of biotechnology use: Industry	Public Administration	17.2
% Units by final application areas of biotechnology use: Industry	Higher Education	63.2
% Units by final application areas of biotechnology use: Industry	Companies	13.0
% Units by final application areas of biotechnology use: Industry	NPPI	6.7
R&D personnel in Biotechnology (PP)	Total	49,624
R&D personnel in Biotechnology (PP)	Public Administration	14,025
R&D personnel in Biotechnology (PP)	Higher Education	18,065
R&D personnel in Biotechnology (PP)	Companies	17,257
R&D personnel in Biotechnology (PP)	NPPI	277
R&D personnel in Biotechnology (PP): Research personnel	Total	31,617
R&D personnel in Biotechnology (PP): Research personnel	Public Administration	8,400
R&D personnel in Biotechnology (PP): Research personnel	Higher Education	13,853
R&D personnel in Biotechnology (PP): Research personnel	Companies	9,195
R&D personnel in Biotechnology (PP): Research personnel	NPPI	169
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Total	18,006
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Public Administration	5,625
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Higher Education	4,212
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Companies	8,061
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	NPPI	108
R&D personnel in Biotechnology (PP). Women	Total	28,374
R&D personnel in Biotechnology (PP). Women	Public Administration	8,817
R&D personnel in Biotechnology (PP). Women	Higher Education	9,391
R&D personnel in Biotechnology (PP). Women	Companies	9,980
R&D personnel in Biotechnology (PP). Women	NPPI	186
R&D personnel in Biotechnology (PP). Women: Research personnel	Total	17,240
R&D personnel in Biotechnology (PP). Women: Research personnel	Public Administration	4,979
R&D personnel in Biotechnology (PP). Women: Research personnel	Higher Education	6,935
R&D personnel in Biotechnology (PP). Women: Research personnel	Companies	5,222
R&D personnel in Biotechnology (PP). Women: Research personnel	NPPI	104
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Total	11,134
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Public Administration	3,838
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Higher Education	2,456
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Companies	4,758
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	NPPI	82
R&D personnel in Biotechnology (FTE)	Total	35,793.8
R&D personnel in Biotechnology (FTE)	Public Administration	10,811.1
R&D personnel in Biotechnology (FTE)	Higher Education	11,886.5
R&D personnel in Biotechnology (FTE)	Companies	12,883.4
R&D personnel in Biotechnology (FTE)	NPPI	212.8
R&D personnel in Biotechnology (FTE): Research personnel	Total	22,776.0
R&D personnel in Biotechnology (FTE): Research personnel	Public Administration	6,354.5
R&D personnel in Biotechnology (FTE): Research personnel	Higher Education	9,188.3
R&D personnel in Biotechnology (FTE): Research personnel	Companies	7,103.2
R&D personnel in Biotechnology (FTE): Research personnel	NPPI	130.0
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Total	13,017.8
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Public Administration	4,456.6
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Higher Education	2,698.2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Companies	5,780.2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	NPPI	82.8
R&D personnel in Biotechnology (FTE). Women	Total	20,951.5
R&D personnel in Biotechnology (FTE). Women	Public Administration	6,766.8
R&D personnel in Biotechnology (FTE). Women	Higher Education	6,436.5
R&D personnel in Biotechnology (FTE). Women	Companies	7,600.6
R&D personnel in Biotechnology (FTE). Women	NPPI	147.6
R&D personnel in Biotechnology (FTE). Women: Research personnel	Total	12,634.4
R&D personnel in Biotechnology (FTE). Women: Research personnel	Public Administration	3,729.2
R&D personnel in Biotechnology (FTE). Women: Research personnel	Higher Education	4,765.0
R&D personnel in Biotechnology (FTE). Women: Research personnel	Companies	4,057.0
R&D personnel in Biotechnology (FTE). Women: Research personnel	NPPI	83.2
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Total	8,317.2
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Public Administration	3,037.6
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Higher Education	1,671.5
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Companies	3,543.7
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	NPPI	64.4
Expenditure on internal R&D in Biotechnology (thousands of euros)	Total	2,748,629
Expenditure on internal R&D in Biotechnology (thousands of euros)	Public Administration	790,000
Expenditure on internal R&D in Biotechnology (thousands of euros)	Higher Education	663,966
Expenditure on internal R&D in Biotechnology (thousands of euros)	Companies	1,283,346
Expenditure on internal R&D in Biotechnology (thousands of euros)	NPPI	11,317
1) By type of expenditure: Current expenditure	Total	2,534,791
1) By type of expenditure: Current expenditure	Public Administration	737,638
1) By type of expenditure: Current expenditure	Higher Education	606,138
1) By type of expenditure: Current expenditure	Companies	1,180,187
1) By type of expenditure: Current expenditure	NPPI	10,827
1.1) Labour expenditure of research personnel	Total	1,028,782
1.1) Labour expenditure of research personnel	Public Administration	268,921
1.1) Labour expenditure of research personnel	Higher Education	383,808
1.1) Labour expenditure of research personnel	Companies	372,421
1.1) Labour expenditure of research personnel	NPPI	3,632
1.2) Labour expenditure of technical and auxiliary personnel	Total	479,176
1.2) Labour expenditure of technical and auxiliary personnel	Public Administration	155,370
1.2) Labour expenditure of technical and auxiliary personnel	Higher Education	91,894
1.2) Labour expenditure of technical and auxiliary personnel	Companies	229,734
1.2) Labour expenditure of technical and auxiliary personnel	NPPI	2,178
1.3) Other current expenditure	Total	1,026,833
1.3) Other current expenditure	Public Administration	313,348
1.3) Other current expenditure	Higher Education	130,437
1.3) Other current expenditure	Companies	578,032
1.3) Other current expenditure	NPPI	5,017
2) By type of expenditure: Capital expenditure	Total	213,838
2) By type of expenditure: Capital expenditure	Public Administration	52,362
2) By type of expenditure: Capital expenditure	Higher Education	57,827
2) By type of expenditure: Capital expenditure	Companies	103,159
2) By type of expenditure: Capital expenditure	NPPI	490
2.1) Land and buildings	Total	28,577
2.1) Land and buildings	Public Administration	5,863
2.1) Land and buildings	Higher Education	11,615
2.1) Land and buildings	Companies	10,889
2.1) Land and buildings	NPPI	210
2.2) Equipment and tools	Total	146,829
2.2) Equipment and tools	Public Administration	45,051
2.2) Equipment and tools	Higher Education	42,322
2.2) Equipment and tools	Companies	59,204
2.2) Equipment and tools	NPPI	253
2.3) Acquisition of specific R&D software	Total	7,338
2.3) Acquisition of specific R&D software	Public Administration	1,354
2.3) Acquisition of specific R&D software	Higher Education	339
2.3) Acquisition of specific R&D software	Companies	5,623
2.3) Acquisition of specific R&D software	NPPI	21
2.4) Other R&D-specific IP products	Total	31,094
2.4) Other R&D-specific IP products	Public Administration	94
2.4) Other R&D-specific IP products	Higher Education	3,552
2.4) Other R&D-specific IP products	Companies	27,442
2.4) Other R&D-specific IP products	NPPI	6
1.1) By origin of funds: Own funds	Total	1,107,216
1.1) By origin of funds: Own funds	Public Administration	99,226
1.1) By origin of funds: Own funds	Higher Education	117,157
1.1) By origin of funds: Own funds	Companies	887,527
1.1) By origin of funds: Own funds	NPPI	3,306
1.2) By origin of funds: Funds from the Business sector	Total	258,957
1.2) By origin of funds: Funds from the Business sector	Public Administration	69,960
1.2) By origin of funds: Funds from the Business sector	Higher Education	42,038
1.2) By origin of funds: Funds from the Business sector	Companies	143,903
1.2) By origin of funds: Funds from the Business sector	NPPI	3,055
1.3) By origin of funds: Funds from the Public Administration sector	Total	1,065,003
1.3) By origin of funds: Funds from the Public Administration sector	Public Administration	512,667
1.3) By origin of funds: Funds from the Public Administration sector	Higher Education	424,208
1.3) By origin of funds: Funds from the Public Administration sector	Companies	126,546
1.3) By origin of funds: Funds from the Public Administration sector	NPPI	1,582
1.4) By origin of funds: Funds from the Higher Education sector	Total	5,113
1.4) By origin of funds: Funds from the Higher Education sector	Public Administration	1,150
1.4) By origin of funds: Funds from the Higher Education sector	Higher Education	3,842
1.4) By origin of funds: Funds from the Higher Education sector	Companies	94
1.4) By origin of funds: Funds from the Higher Education sector	NPPI	27
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Total	51,237
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Public Administration	20,158
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Higher Education	17,468
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Companies	12,623
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	NPPI	988
1.6) By origin of funds: Funds from the rest of the world	Total	261,103
1.6) By origin of funds: Funds from the rest of the world	Public Administration	86,839
1.6) By origin of funds: Funds from the rest of the world	Higher Education	59,252
1.6) By origin of funds: Funds from the rest of the world	Companies	112,652
1.6) By origin of funds: Funds from the rest of the world	NPPI	2,359
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Total	177,658
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Public Administration	38,288
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Higher Education	1,802
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Companies	137,432
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	NPPI	135
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Total	124,133
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Public Administration	34,179
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Higher Education	1,692
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Companies	88,127
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	NPPI	134
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Total	53,525
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Public Administration	4,109
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Higher Education	110
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Companies	49,305
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	NPPI	1
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Total	45.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Public Administration	65.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Higher Education	50.0
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Companies	43.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	NPPI	73.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Total	15.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Public Administration	10.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Higher Education	11.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Companies	16.2
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	NPPI	6.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Total	25.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Public Administration	47.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Higher Education	33.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Companies	23.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	NPPI	20.0
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Total	15.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Public Administration	21.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Higher Education	33.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Companies	14.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	NPPI	6.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Total	20.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Public Administration	27.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Higher Education	44.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Companies	18.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	NPPI	40.0
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Total	21.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Public Administration	29.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Higher Education	41.2
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Companies	19.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	NPPI	6.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Total	17.9
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Public Administration	7.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Higher Education	10.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Companies	19.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	NPPI	13.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Total	49.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Public Administration	47.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Higher Education	44.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Companies	49.8
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	NPPI	33.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Total	59.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Public Administration	59.5
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Higher Education	60.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Companies	59.4
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	NPPI	73.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Total	22.1
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Public Administration	20.7
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Higher Education	17.6
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Companies	22.3
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	NPPI	33.3